Literature DB >> 16707369

Reproducibility of MDM2 and CDK4 staining in soft tissue tumors.

Matthieu Bui Nguyen Binh1, Xavier Sastre Garau, Louis Guillou, Alain Aurias, Jean-Michel Coindre.   

Abstract

MDM2 and CDK4 immunostaining can be useful adjuncts in diagnosing liposarcoma among soft tissue neoplasms. We examined the reproducibility of MDM2 and CDK4 staining between 2 laboratories and between tissue microarrays and whole tissue sections. Sixty-two soft tissue tumors were immunostained at the Bergonié Institute, Bordeaux, France, and the Curie Institute, Paris, France. We also examined 203 soft tissue neoplasms on standard tissue sections and tissue microarrays. There was high concordance of results obtained from the 2 laboratories (with 2 different pathologists) for MDM2 (kappa, 0.93) and CDK4 (kappa, 0.8) staining. There also was excellent concordance between results on tissue microarray and on whole tissue sections for MDM2 (kappa, 0.80) and CDK4 (kappa, 0.93). Immunostaining for MDM2 and CDK4 is a reproducible technique that may be exported to different laboratories for routine use. Tissue microarray is indicated for studying large series.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707369     DOI: 10.1309/VMBP-67QU-NN6Q-3J0E

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  [Sarcoma of the spleen with MDM2 expression].

Authors:  T Hansen; U Titze; A Deeb; B Eikötter; M Schütz; H U Schildhaus
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

2.  Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.

Authors:  Hiroaki Kimura; Yoh Dobashi; Takayuki Nojima; Hiroyuki Nakamura; Norio Yamamoto; Hiroyuki Tsuchiya; Hiroko Ikeda; Seiko Sawada-Kitamura; Takeru Oyama; Akishi Ooi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

3.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

Review 4.  Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Authors:  Adrián Mariño-Enríquez; Judith V M G Bovée
Journal:  Surg Pathol Clin       Date:  2016-09

5.  Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?

Authors:  Hanan Alshenawy
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-26       Impact factor: 4.553

6.  Diagnostic importance of clinicopathologic features and p16, CD34, MDM2 expression in differential diagnosis of adipocytic tumors.

Authors:  Eren Altun; Seher Yüksel; Gülşah Kaygusuz; Hüseyin Yusuf Yıldız
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

7.  Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.

Authors:  Khin Thway; Jayson Wang; John Swansbury; Toon Min; Cyril Fisher
Journal:  Sarcoma       Date:  2015-02-25

8.  CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen.

Authors:  Sanghoon Lee; Hyojun Park; Sang Yun Ha; Kwang Yeol Paik; Seung Eun Lee; Jong Man Kim; Jae Berm Park; Choon Hyuck David Kwon; Jae-Won Joh; Yoon-La Choi; Sung Joo Kim
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.